ReviewCurrent hematologic malignancy reports2016
T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies.
Nasheed M Hossain et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it